跳至主要内容
临床试验/NL-OMON43346
NL-OMON43346尚未招募不适用

Searching for Explanations for Cryptogenic Stroke in the<br>Young: Revealing the Etiology, Triggers, and Outcome - SECRETO

Helsinki University Central Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Ischemic stroke
  • Age 18 - 49 years
  • Hospitalized due to first-ever imaging postive ischemic stroke without cause found after complete and timely minimum diagnostic testing

排除标准

  • Baseline mandatory minimum tests not obtained in the first week following stroke onset,
  • a. Brain MRI
  • b. Routine blood tests, including complete blood count with differential, CRP, fasting glucose,
  • creatinine, aPTT, INR, total cholesterol, LDL-cholesterol, HDL-cholesterol, HbA1C, and
  • hemoglobin electrophoresis in individuals of African origin
  • Other baseline mandatory minimum tests not obtained within the first two weeks following
  • stroke onset, including:
  • a. Imaging of cervicocephalic arteries by CTA, MRA, or DSA
  • b. Transesophageal (highly recommended) and/or transthoracic echocardiography (N.B. Early
  • screening of venous thrombosis in the lower extremities is highly recommended in patients
  • with established right-to-left shunt)
  • c. 24-hour Holter monitoring (or continuous in-hospital ECG monitoring for at least 24 h)
  • d. Screening for thrombophilia, including anticardiolipin antibodies, lupus anticoagulant, anti-β2-
  • glycoprotein antibodies, factor V mutation (or aPC resistency ruled out), factor II mutation,
  • homocysteine, antithrombin III, protein C, and protein S. It is highly recommended to retest
  • any abnormal finding >12 weeks from the initial testing or >4 weeks after cessation of
  • anticoagulation at any later time point.

研究者

相似试验